Hjem › Lupus-nefritt › North Carolina
Kliniske studier for Lupus-nefritt i North Carolina
11 studier for Lupus-nefritt søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of North Carolina at Chapel Hill, Chapel Hill
RekruttererFase 2
Alder 8 til 20 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Cross Creek Medical Clinic, Fayetteville
RekruttererFase 2
Alder 12 til 70 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Chapel Hill
- Research Site, Charlotte
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of North Carolina TraCS Institute - CTRC, Chapel Hill
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
- Joint and Muscle Research Institute, Charlotte
RekruttererFase 4
Alder 18 til 75 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07611214A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07115745Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
- GSK Investigational Site, Charlotte
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06527872A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
RekruttererFase 1
Alder 12 til 70 · Alle kjønn · Oppdatert 22. mai 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- UNC Chapel Hill, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 til 110 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT05934149Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.